Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

NCT06100367 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT06100367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06100367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Lead sponsor
Changi General Hospital
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
December 30, 2019
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal tumors, primary aldosteronism, primary aldosteronism due to aldosterone producing adenoma